These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9446410

  • 41. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
    Manne U, Gary BD, Oelschlager DK, Weiss HL, Frost AR, Grizzle WE.
    Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Correlations between clinicopathological parameters and molecular signatures of primary tumors for patients with stage T3n0 colorectal adenocarcinomas: a single center retrospective study on 100 cases.
    András C, Tóth L, Molnár C, Tanyi M, Csiki Z, Dezso B, Pósán J, Shemirani AH, Csiki E, Szántó J.
    Hepatogastroenterology; 2012 Jun; 59(116):1091-7. PubMed ID: 22414548
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast.
    Visscher DW, Sarkar FH, Wykes S, Kothari K, Macoska J, Crissman J.
    Arch Pathol Lab Med; 1993 Oct; 117(10):973-6. PubMed ID: 8215837
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas.
    Lapertosa G, Baracchini P, Delucchi F.
    Pathologica; 1994 Apr; 86(2):170-3. PubMed ID: 7936761
    [Abstract] [Full Text] [Related]

  • 53. Ki67 immunohistochemical evaluation in colorectal cancer and normal colonic mucosa. Possible clinical applications.
    Berenzi A, Benetti A, Bertalot G, Rodolfi A, Portolani N, Giulini SM, Pulcini G, Vinco A, Tiberio G.
    Pathologica; 1992 Apr; 84(1090):155-63. PubMed ID: 1437304
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The prognostic value of human chorionic gonadotropin expression in colorectal adenocarcinomas. An immunohistochemical study of 102 stage B2 and C2 nonmucinous adenocarcinomas.
    Connelly JH, Johnston DA, Bruner JM.
    Arch Pathol Lab Med; 1993 Aug; 117(8):824-6. PubMed ID: 8343047
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Proliferation of cancer cells and stromal cells in colorectal adenocarcinomas as assessed with anti-PCNA/cyclin monoclonal antibody.
    Markiewski M, Zbisławski W, Marlicz W, Domagała W.
    Pol J Pathol; 1996 Aug; 47(3):101-4. PubMed ID: 8952339
    [Abstract] [Full Text] [Related]

  • 60. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables.
    Lanza G, Cavazzini L, Borghi L, Ferretti S, Buccoliero F, Rubbini M.
    Pathol Res Pract; 1990 Oct; 186(5):608-18. PubMed ID: 2287588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.